Investors Research Corp’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7K Sell
1,009
-14
-1% -$167 ﹤0.01% 505
2026
Q1
$6.13K Sell
1,023
-19
-2% -$143 ﹤0.01% 590
2025
Q4
$7.47K Sell
1,042
-20
-2% -$158 ﹤0.01% 645
2025
Q3
$11.3K Hold
1,062
﹤0.01% 627
2025
Q2
$10.3K Hold
1,062
﹤0.01% 666
2025
Q1
$15.8K Hold
1,062
﹤0.01% 626
2024
Q4
$15.8K Hold
1,062
﹤0.01% 626
2024
Q3
$20.3K Hold
1,062
﹤0.01% 603
2024
Q2
$22K Hold
1,062
0.01% 612
2024
Q1
$20K Sell
1,062
-25
-2% -$429 ﹤0.01% 618
2023
Q4
$15.7K Hold
1,087
﹤0.01% 673
2023
Q3
$18.9K Hold
1,087
﹤0.01% 652
2023
Q2
$22.6K Hold
1,087
0.01% 628
2023
Q1
$25.6K Hold
1,087
0.01% 624
2022
Q4
$30.4K Hold
1,087
0.01% 595
2022
Q3
$25K Hold
1,087
0.01% 605
2022
Q2
$37K Buy
+1,087
New +$38.1K 0.01% 557
2022
Q1
Sell
-1,123
Closed -$34K 1073
2021
Q4
$34K Hold
1,123
0.01% 576
2021
Q3
$37K Hold
1,123
0.01% 568
2021
Q2
$34K Buy
+1,123
New +$37K 0.01% 583

Other funds holding OGN

Investors Research Corp's OGN Position: Q2 2026 in Review

Investors Research Corp reduced its Organon & Co (OGN) stake by 1.4% in Q2 2026, selling an estimated $167 and leaving 1,009 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #505.

Investors Research Corp first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $37K in Q2 2022. 115 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Investors Research Corp held 1,009 shares of Organon & Co worth $13.7K as of Q2 2026.
  • Investors Research Corp sold 14 Organon & Co shares in Q2 2026, an estimated $167.
  • Organon & Co made up ﹤0.01% of Investors Research Corp's portfolio in Q2 2026, its #505 holding.
  • Investors Research Corp first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • Investors Research Corp's Organon & Co position peaked at $37K in Q2 2022.
  • 115 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Investors Research Corp's 13F filing for Q2 2026, filed 10 Jul 2026.